Ignite Creation Date:
2024-05-06 @ 8:07 PM
Last Modification Date:
2024-10-26 @ 3:20 PM
Study NCT ID:
NCT06250400
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-02-09
First Post:
2024-01-15
Brief Title:
Efficacy and Safety of Histamine Human Immunoglobulin in the Treatment of Chronic Spontaneous Urticaria CSU
Sponsor:
Hangzhou Grand Biologic Pharmaceutical Inc
Organization:
Hangzhou Grand Biologic Pharmaceutical Inc
Study Overview
Official Title:
A Multicenter Randomized Double-blind Placebo-Controlled Parallel StudyClinical Study of Efficacy and Safety of Histamine Human Immunoglobulin ShuYangMinNing in the Treatment of Chronic Spontaneous Urticaria CSU
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The goal of this clinical trial is to study patients with chronic spontaneous urticaria The main question it aims to answer is the efficacy and safety of histamine human immunoglobulin ShuYangMinNing in the treatment of chronic spontaneous urticaria
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None